Vol. 17 No. 4 (2013)
ACQUIRED HEART DISEASES

Correction of moderate secondary mitral regurgitation due to aortic valve disease: immediate results

V. Nazarov
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
S. Zheleznev
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
I. Demin
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
K. Smolyaninov
District Clinical Hospital of the Khanty-Mansiysk Autonomous Okrug - Ugra
Bio
A. Afanasev
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
S. Lavinyukov
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio

Published 2013-10-10

Keywords

  • AORTIC VALVE REPLACEMENT,
  • SECONDARY MODERATE MITRAL REGURGITATION

How to Cite

Nazarov, V., Zheleznev, S., Demin, I., Smolyaninov, K., Afanasev, A., & Lavinyukov, S. (2013). Correction of moderate secondary mitral regurgitation due to aortic valve disease: immediate results. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 17(4), 7–10. https://doi.org/10.21688/1681-3472-2013-4-7-10

Abstract

To evaluate the impact of surgical strategy in concomitant mitral valve surgery or isolated aortic valve replacement (AVR) in patients with moderate secondary mitral regurgitation (MR), 1 574 patients underwent AVR over a period from January 2003 to December 2011. 241 patients had secondary MR 2+ and constituted the study population. Patients were stratified into two groups, those without concomitant mitral valve surgery (Group A, n = 113) and with it (Group B, n = 128). It was found out that AVR plastic correction of MI reduces its recurrence during short-term follow-up but increases the intervention time leading to an insignificant rise in lethality. In patients with aortic stenosis the age exceeding 70 years and the presence of atrial fibrillation are found to be the most significant predictors of preservation of residual mitral regurgitation in the early postoperative period, while more indicative for patients with aortic insufficiency is the presence of tricuspid regurgitation grade 2 or higher.

References

  1. Sabbah H.N. et ai. // Am. J. Cardioi. 1993. V. 72. Р. 1074-1076.
  2. Moazami N., Diadato M.D., Moon M.R. et ai. // J. Card. Sur. 2004. V. 19. P. 444-448.
  3. Ruei M., Kapiia V. et ai. // Circuiation. 2006. V. 114. Р. 541-546.
  4. Absii B., Dagenais F., Mathieu P. et ai. // Eur. J. Cardiothorac. Sug. 2003. V. 24. Р. 217-222.
  5. The Joint Task Force on the Management of Vaivuiar Heart Disease of the European Society of Cardioiogy (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2012.
  6. Караськов А.М., Тураев Ф.Ф., Железнев С.И. и др. // Патология кровообращения и кардиохирургия. 2010. № 1. С. 21-25.
  7. Караськов А.М., Шматов Д.А., Железнев С.И. и др. // Патология кровообращения и кардиохирургия. 2010. № 4. С. 33-38.
  8. Grigioni F., Zehr K. et ai. // Circuiation. 2001. V. 103. Р. 1759-1764.
  9. Trichon B. et ai. // Am. J. Cardioi. 2003. V. 91. Р. 538-543.
  10. Grossi E.A., Patei N., Woo Y.J. et ai. // J. Am. Coii Cardioi. 2010. V. 56. Р. 1984-1993.
  11. Barreiro C.J. et ai. // Circuiation. 2005. V. 112. Р. I-443-I-447.
  12. Koji Takeda, Goro Matsumiya et ai. // Eur. J. Cardiothorac. Surg. 2010. V. 37. Р. 1033-1038.
  13. Caivin W., Suri R., Li Z. et ai. // J. Thorac. Cardiovasc. Surg. 2009. V. 137. Р. 635-640.
  14. Coutinho G.F., Correia P.M., Pancas R. et ai. // Eur. J. Cardiothorac. Surg. 2013. V. 44 (1). Р. 32-40.
  15. Астапов Д.А., Караськов А.М., Исаян М.В., Семенова Е.И., Демидов Д.П., Опен А.Б. // Патология кровообращения и кардиохирургия. 2012. № 1. С. 23-26.